Optimization studies on gastroretentive floating system using response surface methodology

AAPS PharmSciTech

Volumn 13, Issue 1, 2012, Pages 85-93

  Awasthi, Rajendra ^a   Kulkarni, Giriraj T ^a   Pawar, Vivek K ^b   Garg, Garima ^c  

^a Laureate Institute of Pharmacy   (India)

^b Kusum Heathcare   (India)

^c MEERUT INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

Author keywords

Amoxicillin; Central composite design; Floating microballoons; Gastroretentive floating system; H. pylori; Response surface methodology

Indexed keywords

AMOXICILLIN; CELLACEFATE; DICHLOROMETHANE; EUDRAGIT;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; ENCAPSULATION; GASTRORETENTIVE FLOATING SYSTEM; PARTICLE SIZE; PRIORITY JOURNAL; RESPONSE SURFACE METHOD; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

AMOXICILLIN; CHEMISTRY, PHARMACEUTICAL; HELICOBACTER INFECTIONS; MICROSPHERES; PARTICLE SIZE; STOMACH; SURFACE PROPERTIES; X-RAY DIFFRACTION;

EID: 84861098235     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-011-9730-y     Document Type: Article

References (16)

1. Majumdar D, Bebb J, Atherton J. Helicobacter pylori infection and peptic ulcers. Medicine. 2007;35:204-9. (Pubitemid 46442164)
2. Bardronnet P, Faivre V, Pugh WJ, Piffaretti JC, Falson F. Gastroretentive dosage forms: overview and special case of Helicobacter pylori. J Control Release. 2006;111:1-18. (Pubitemid 43289989)
3. Selgrad M, Malfertheiner P. New strategies for Helicobacter pylori eradication. Curr Opin Pharmacol. 2008;8:1-5.
4. Davis SS. Formulation strategies for absorption window. Drug Discov Today. 2005;10:249-57.
5. Talukder R, Fassihi R. Gastroretentive drug delivery system: a mini review. Drug Dev Ind Pharm. 2004;30:1019-28. (Pubitemid 39577994)
6. Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery system: a review. AAPS Pharm. Sci. Tech. 2005; 6 Article-47. http://www.aapspharmscitech.org. Accessed on 05.06.2010
7. Choudhury PK, Kar M, Chauhan CS. Cellulose acetate microspheres as floating depot system to increase gastric retention of antidiabetic drug: formulation, characteristics and in vitro-in vivo evaluation. Drug Dev Ind Pharm. 2008;34:349-54. (Pubitemid 351519667)
8. Soppimath KS, Aminabhavi TM, Agnihotri SA, Mallikarjuna NN, Kulkarni PV. Effect of coexipients on nifedipine hollow microspheres: a novel gastroretentive drug delivery system. J Appl Polym Sci. 2006;100:486-94.
9. Varshosaz J, Tabbakhian M, Zahrooni M. Development and characterization of floating microballoons for oral delivery of cinnarizine by a factorial design. J Microencapsul. 2007;24:253-62. (Pubitemid 46567408)
10. Prajapati ST, Patel LD, Patel DM. Gastric floating matrix tablets: design and optimization using combination of polymers. Acta Pharm. 2008;58:221-9.
11. Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. In-vitro and in-vivo evaluation of riboflavin-containing microballoons for a controlled drug delivery system in healthy humans. Int J Pharm. 2004;275:97-107. (Pubitemid 38481523)
12. Lee JH, Park TG, Choi HK. Development of oral drug delivery system using floating microspheres. J Microencapsul. 1999;16:715-29. (Pubitemid 29478951)
13. Nepal PR, Chun MK, Choi HK. Preparation of floating microspheres for fish farming. Int J Pharm. 2007;341:85-90. (Pubitemid 47088111)
14. Patel JK, Patel MM. Stomach specific anti-Helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres. Curr Drug Deliv. 2007;4:41-50. (Pubitemid 46066413)
15. Jain SK, Awasthi AM, Jain NK, Agrawal GP. Calcium silicate based microspheres of repaglinide for gastroreteneive floating drug delivery: preparation and in-vitro characterization. J Control Release. 2005;107:300-9. (Pubitemid 41316292)
16. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60:110-1.